Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
– Sell
-15,200
Closed -$40K – 803
2020
Q2
$40K Sell
15,200
-414,170
-96% -$977K ﹤0.01% 778
2020
Q1
$1.96M Hold
429,370
– – 0.02% 534
2019
Q4
$2M Buy
429,370
+273,649
+176% +$1.21M 0.02% 550
2019
Q3
$719K Sell
155,721
-251,979
-62% -$1.21M 0.01% 648
2019
Q2
$1.9M Buy
407,700
+368,970
+953% +$1.65M 0.02% 531
2019
Q1
$167K Hold
38,730
– – ﹤0.01% 782
2018
Q4
$152K Hold
38,730
– – ﹤0.01% 774
2018
Q3
$177K Hold
38,730
– – ﹤0.01% 782
2018
Q2
$179K Buy
38,730
+5,600
+17% +$32.9K ﹤0.01% 761
2018
Q1
$241K Hold
33,130
– – ﹤0.01% 733
2017
Q4
$214K Hold
33,130
– – ﹤0.01% 736
2017
Q3
$218K Buy
33,130
+680
+2% +$4.21K ﹤0.01% 713
2017
Q2
$178K Hold
32,450
– – ﹤0.01% 696
2017
Q1
$187K Sell
32,450
-11,000
-25% -$60.4K ﹤0.01% 683
2016
Q4
$213K Buy
43,450
+14,650
+51% +$79.1K ﹤0.01% 652
2016
Q3
$175K Hold
28,800
– – ﹤0.01% 652
2016
Q2
$170K Hold
28,800
– – ﹤0.01% 650
2016
Q1
$148K Buy
+28,800
New +$133K ﹤0.01% 631

Other funds holding ABEV

Candriam SCA's ABEV Position: Q3 2020 in Review

Candriam SCA sold out of Ambev (ABEV) in Q3 2020, closing a stake of 15,200 shares — an estimated $40K sold.

Candriam SCA first reported a position in ABEV in Q1 2016 and held it in 18 quarters. The position peaked at $2M in Q4 2019. 267 funds tracked by Wall St. Rank hold ABEV as of Q3 2020.

  • Candriam SCA reported no remaining Ambev position as of Q3 2020 after selling out during the quarter.
  • Candriam SCA sold 15,200 Ambev shares in Q3 2020, an estimated $40K.
  • Candriam SCA first reported a position in Ambev in Q1 2016 and held it in 18 quarters.
  • Candriam SCA's Ambev position peaked at $2M in Q4 2019.
  • 267 funds tracked by Wall St. Rank held Ambev as of Q3 2020.

Based on Candriam SCA's 13F filing for Q3 2020, filed 19 Oct 2020.